PharmaDeals: PharmaDeals Review: Table of Contents

<< Previous Issue

Aug 2005 (Vol: 2005, Issue: 62)

Next Issue >>

Section: Business Commentaries
Biotechnology Means Hope Published: 1 Aug-2005
By: Fintan Walton
Abstract Fulltext:
Section: Company Profile
Arrow Therapeutics Ltd. Published: 5 Aug-2005
By: Business Review Editor
Abstract Fulltext:
Section: Deal Trackers
Byetta (exenatide) Published: 5 Aug-2005
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Procter & Gamble to Co-Promote Novartis’ Enablex® Published: 5 Aug-2005
By: Business Review Editor
Abstract Fulltext:
Section: Features
Alkermes, Cephalon and Vivitrex#174;: Pioneering the Alcohol Dependence Market Published: 1 Aug-2005
By: Business Review Editor
Abstract Fulltext:
Pfizer and Vicuron: A Taste of Things to Come? Published: 1 Aug-2005
By: Business Review Editor
Abstract Fulltext:
The Supreme Court Changes Biotech Deal Flow Published: 1 Aug-2005
By: Business Review Editor
Abstract Fulltext:
Therapy Focus: Acute Myeloid Leukaemia Published: 1 Aug-2005
By: Business Review Editor
Abstract Fulltext:
Section: General
Merck and Metabasis Target Metabolic Diseases Published: 5 Aug-2005
By: Business Review Editor
Abstract
Section: Licensing
Arrow and Novartis Agree on RSV Published: 5 Aug-2005
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Salix to Acquire InKine in Gastrointestinal Merger Published: 5 Aug-2005
By: Business Review Editor
Abstract Fulltext:
UK Acquisitions Hit the Headlines Published: 5 Aug-2005
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
GlaxoSmithKline and Vitae Sign Hypertension Collaboration Published: 5 Aug-2005
By: Business Review Editor
Abstract Fulltext:

Login

Username:

Password:

Keep me logged in

Bookmarks

Bookmark PharmaDeals through one of these social networks.